IRCT20210211050323N1已完成2 期
Clinical trial to evaluate the effect of rosuvastatin adjuvant therapy on oxidative stress factors in the treatment of multiple sclerosis
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 70 years（—）
- 性别
- All
入选标准
- •History of multiple sclerosis at least one year ago
- •Radiographic findings of magnetic resonance imaging ( MRI ) consistent with the clinical diagnosis of multiple sclerosis
- •No other concomitant inflammatory disease
- •Bad cholesterol levels (low-density lipoprotein) less than 130 mg / dL
- •No pregnancy and lactation
- •The consistency of the main treatment of patients and the use of a specific type of drug
- •Do not take medications other than standard treatments for multiple sclerosis that alter the levels of the factors under consideration.
- •Do not use any combination with antioxidant effects in the past month.
排除标准
- •Existing evidence based on increased patient disability
- •Consumption of any combination or drug with antioxidant effects except prescription drugs
- •Existence of any cognitive or behavioral disorders that lead to the patient not cooperating.
研究者
相似试验
尚未招募
2 期
The effect of rosuvastatin in multiple sclerosisMultiple sclerosisIRCT20210211050323N3Hamedan University of Medical Sciences40
招募中
2 期
The effect of rosuvastatin in multiple sclerosisMultiple sclerosisIRCT20210211050323N2Hamedan University of Medical Sciences40
进行中（未招募）
1 期
A randomised placebo controlled trial of rosuvastatin in systemic lupus erythematosus. - RCT of statin in SLESystemic lupus erythematosus.MedDRA version: 13.1 Level: LLT Classification code 10042944 Term: Systemic lupus erythematosis System Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2006-006214-16-GBImperial College64
已完成
不适用
A study to evaluate the efficacy of Rosuvastatin for patients with coronary plaque utilizing aggressive lipid lowering treatmentHypercholesterolemiaJPRN-UMIN000001223Kokura Memorial Hospital400
招募中
2 期
Rosuvastatin in patients with moderate brain traumaModerate traumatic brain injury.Diffuse traumatic brain injuryS06.2IRCT20230627058603N2Esfahan University of Medical Sciences200